SABINA SISIC: Open Payments
NPI 1700370491 · JEFFERSONVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,197 in 41 payments from 11 companies in 2025. Trend: 2023 $1,764 · 2024 $994 · 2025 $1,197
Food & beverage: $1,197
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 21 | $750 |
| Sumitomo Pharma America, Inc. | 7 | $151 |
| Ferring Pharmaceuticals Inc. | 4 | $78 |
| Procept Biorobotics Corporation | 1 | $50 |
| ABBVIE INC. | 2 | $44 |
| Endo USA, Inc. | 1 | $24 |
| Alnylam Pharmaceuticals Inc. | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
| Merck Sharp & Dohme LLC | 1 | $21 |
| Antares Pharma, Inc. | 1 | $18 |
Products named: INTERSTIM, ALTAVIVA, GEMTESA, ADSTILADRIN, AQUABEAM ROBOTIC SYSTEM, ORGOVYX, BOTOX, XIAFLEX.
Industry payments across IN — which companies pay providers there.
